Pacific Biomarkers, Inc. (PBME.OB) Announces Quarterly Results
Pacific Biomarkers Inc., Seattle based provider of specialized central laboratory and contract research services supporting pharmaceutical and diagnostic manufacturers, today reported financial results for the second quarter of FY2010, together with first half results for the fiscal year. Revenue for the three months ended December 31, 2009 (their second quarter FY2010), decreased 35%, to $2,113,795, compared with the same quarter last year, and decreased 8% compared with the previous quarter. The company reported an operating loss of $307,037 (and net loss of $457,629) for the quarter, versus an operating income of $554,505 (and net income of $976,671) for the same…